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ormed the informed consent for the abscess puncture procedure.
he length of tuak consumption was also recorded.
Results: There were 104 patients conducted the study, 93
89.4%) were men which aged 40 – 49 years old are the highest
revalence (n=28; 26.9%). Tender hepatomegaly was found in 93
89.4%)which 87 (83.6%) among themwere right lobe liver abscess,
ight upper abdominal quadrant pain occurred in 98 (94.2%), fever
n 89 (85.6%), and leukocytosis in 79 (75.9%) patients. A right lobe
epatic abscess was seen in 87 (83.6%) patients. Tuak was con-
umed by 91 (87.5%) for 5-10 years. Liver puncture was performed
n 79 (76%) patients and we evacuated liquid with variable color,
nd thebacterial cultureswere all negative and the amoebawasnot
ound in all of the samples. All of the patients showed improvement
fter medication.
Conclusion: The presentations of ALA in Medan are mainly
ight upper abdominal quadrant pain, fever, tender hepatomegaly,
eukocytosis, affect the righthepatic lobe, age40-49years old,male,
hus a male presented those symptoms with history of tuak con-
umption increases our suspicion of amoebic liver abscess. Amoeba
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ole of vitamin molecules on host gene down regulation and
ffect on Leishmania donovani infection in an experimental ani-
al model
.R. Gogulamudi ∗, R. Sehgal
PGIMER, Chandigarh, India
Background:Vitamins have as long as been recognized for their
rotective role against tuberculosis. Several studieshave shown the
ole of vitamin D status in tuberculosis patients. Recently, a gene
oding for tryptophan-aspartate containing coat protein (TACO)
asbeen recognized toplay a crucial role in the survival ofMycobac-
erium tuberculosis within human macrophages and host molecule
ACOhas been shown toplay a important role in the arrest of such a
aturation process. Studies showed that synergistic action of Vita-
in D3 and Retinoic acid had inherent ability to down-regulate
ACO gene transcription in human macrophages and this leads to
arly maturation of phagosome and pathogen elimination. We are
ostulating that a similar stable association of TACO with phago-
omes would prevent the vacuole from maturation, with a role of
ACO in this process in case of Leishmania.
Methods: The present study evaluated the effect of treatment
ith Vitamin D3/Retinoic acid & Chenodeoxycholic acid/Retinoic
cid combinations on Leishmania donovani infection in BALB/c
ouse model. Animals were sacriﬁced at different time intervals.
arasite load was determined in the impression smears of liver and
pleen of control and drug treated animals. histological examina-
ions at different time intervels.
Results: Itwas found theparasite loadandweights of spleenand
iver increased till day 28 post infection in control mice, whereas in
ice treated with above-mentioned drugs there was a signiﬁcant
ecline inweights of the organs andparasite load ondays 21 and28fectious Diseases 16S (2012) e158–e316
post treatment. There was also a marked healing of post treatment
and also observed in histology.
Conclusion: Our results elucidate that the Vitamin D3/Retinoic
acid and Chenodeoxycholic acid/Retinoic Acid treatment led to sig-
niﬁcant suppression of weights of spleen, liver and parasite load.
Healing responses in histological specimens of above molecules
treated animals response suggested that the drug treatment down
regulated TACO gene expression as was observed in our in-vitro
experiments. Vit-D3/Retinoic acid combination showing a signiﬁ-
cant level of parasite suppression with better immune modulation
in comparison with the Chenodeoxycholic acid/retinoic acid com-
bination. These observations suggest that Vit-D3/Retinoic acid and
Chenodeoxycholic acid/Retinoic acidmay possibly be an important
adjunct to the treatment of Leishmaniasis.
http://dx.doi.org/10.1016/j.ijid.2012.05.692
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inate between clinical isolates of contrasted virulence
F. Guerfali 1,∗, R.M. Sghaier1, D. Laouini1, L. Guizani-Tabbane2, F.
Ottones3, K. Ben-Aissa2, J. Marti 3, K. Dellagi1
1 Institut Pasteur de Tunis, Tunis-Belvedere, Tunisia
2 Institut Pasteur de Tunis, Tunis, Tunisia
3 Université Montpellier II, Montpellier, France
Background: Leishmaniasis is a vector borne parasitic disease
affectingmillions of peopleworldwide that causes different clinical
manifestations classiﬁedas cutaneous,muco-cutaneous, or visceral
depending on the infecting specie. Zoonotic cutaneous leishma-
niasis (ZCL) caused by Leishmania (L.) major clinically presents as
localized self-healing cutaneous soreswith a broad range of clinical
variations. Whether this clinical spectrum could reﬂect a differen-
tial role playedby L.major in disease outcomeand severity has been
very little investigated.
Our hypothesis is that genetic variation among L. major par-
asites, possibly acting at the level of virulence genes expression,
might impact, in concert with the host immune response, on the
clinical polymorphism of ZCL (severe vs. benign disease or asymp-
tomatic infection).
In an attempt to correlate parasite diversity with disease
outcome, our goal was to establish a list of selected putative
virulence-associated genes that could discriminate between L.
major isolates collected from the ﬁeld.
Methods: Human blood derived macrophages were in vitro
infected with two L. major strains expressing contrasted viru-
lence (high vs. low virulence) according to their experimental
pathogenicity in Balb/C. Our approach was ﬁrst based on a high
throughput transcriptome analysis, namely Serial Analysis of Gene
Expression. More than two hundred parasite transcripts showed
differential expression between the high- or low-virulent strains
at their intracellular infectious stage. Among transcripts that we
could conﬁdently assign to their related gene, four (LmjF26.1710,
LmjF28.2205, LmjF33.1740 and LmjF33.1750) were tested on
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Results: Our results demonstrate an isolate-dependent and
tage-dependent regulation of these genes for a new set of tested
onors, raising the interest in scaling-up the donors and parasite
solates to be tested.
Conclusion: The selected set of putative virulence-associated
enes will be used to classify ﬁeld-collected isolates according to
heir putative virulence.
(This work was supported by NIAID/NIH Grant # 5P50AI074178
nd a joint action Laboratoire International Associé of the Tunisian
inistry for Higher Education, Research and Technology/ French
entre National de Recherche Scientiﬁque).
ttp://dx.doi.org/10.1016/j.ijid.2012.05.693
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he efﬁcacy of artemether-lumefantrine in treating uncompli-
atedmalaria: a study in Samarinda, EastKalimantan, Indonesia
. gunawan1,∗, P. Amaliana2
A. Wahab Sjahranie General Hospital, Samarinda, Indonesia
Mulawarman University School of Medicine, Samarinda, Indonesia
Background: Resistance to antimalarial drugs such as chloro-
uine, sulfadoxin-pyrimethamine has been reported from almost
ll endemic areas in the world, including Indonesia. Some stud-
es in Indonesia showed plasmodium resistance to chloroquine or
ulfadoxin-pyrimethaminewere from20% to as high as 80%. There-
ore, these drugs should be replaced by artemisinin derivatives that
urrently known as the most potent antimalarial. Artemisinin Com-
ination Therapy (ACT) has been used in Indonesia since 2004 and
ow there are three ACTs recommended by The Ministry of Health.
he aim of this study is to evaluate the efﬁcacy of artemether-
umefantrine in treating uncomplicated malaria.
Methods: This study was conducted at A. Wahab Sjahranie
eneral Hospital Samarinda, East Kalimantan, Indonesia from
anuary 2010 to December 2011. Subjects were uncomplicated
dult malaria patients treated with ﬁxed-dose combination of
0mg artemether and 120mg of lumefantrine (Coartem®) 1 tablet
very 12hours for 3 days. The variables measured were fever clear-
nce time (FCT) and parasite clearance time (PCT)
Results: During the period of 24months, therewere 47 patients
ulﬁlled the criteria of this study, consisting of 45 males (95.83%)
nd 2 females (4.17%). Age distribution was as follow: 15-24 years
0 (22.92%), 25-44 years 30 (62.50%), 45-64 years 7 (14.58%). There
ere 26 patients (56.25%) infected by P. falciparum and 21 (43.75%)
y P. vivax. MeanFCT in the group infected by P. falciparum was
6.6hours and in group infected by P. vivax was 7.1 hours. On the
hird day of treatment (D3), all subjects were free of fever. Mean
CT for P. falciparum groupwas 1.92 days and for P. vivax group 1.90
ays. On D3, 92.3% of P. falciparum group were free of parasites and
n the P. vivax group95.2%. OnD4, all patientswere free of parasites.
o patients developed into severe malaria. No signiﬁcant adverse
ffects were found in this study.
Conclusion: Artemether-lumefantrine has high efﬁcacy against
ncomplicated falciparum and vivax malaria. Adequate clinical andfectious Diseases 16S (2012) e158–e316 e161
parasitological response (ACPR) is found 92.3% for P. falciparum and
95.2% for P. vivax.
http://dx.doi.org/10.1016/j.ijid.2012.05.694
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Pulmonary embolism revealing a cardiac hydatic disease
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Background: The cardiac hydatidosis is a rare and serious
localization which can complicate of an arterial hypertension pul-
monary (PH) consequence of a secondary pulmonary embolism in
the rupture of the hydatid cysts (HC) in the right cardiac cavities or
a ﬁstulization of a hepatic HC in the inferior vena cava (IVC).
Methods: To review 2 cases reports to illustrates a unusual eti-
ology of PH
Results: Case report 1: 37 years old woman is investigated
a lung and renal syndrome mimiking ANCA vasculitis. Medical
history begins a few weeks rather with a acute dyspnoea mim-
icking embolism disease and leading to the diagnosis of a release
of pulmonary ball. The degradation of the renal function requir-
ing 9 sessions of hemodialysis which allows to get back the renal
function. An bilateral pulmonary embolism at the origin of a pul-
monary hypertension (PH) is observed in the following up. The
cardiac MRI make the diagnosis of HC localized in the right ventri-
cle complicatedwith a hydatic pulmonary embolism. Liver scanner
tomography imaging does not localizeHC at the hepatic level nor at
the level of the IVC. The patient receives a symptomatic treatment
and is transferred in thoracic and cardiac surgery.
Case report 2: 27-year-old man in the history of bilateral lung-
wort hydatidos witch was operated three years among devellops
an pulmonary embolism revealed by an acute dyspnoea and a
hemoptysis. The data of the thoracic angioscan conﬁrms an sec-
ondary bilateral massive pulmonary embolism in the rupture of a
cardiac HC of the right ventricle. So the patient beneﬁts a cardiac
surgery (cystectomy) under extracorporeal circulation. The imme-
diate course is favorable. However in 3 months of the intervention
the patient is seen again for a dyspnoea stage III of NYHAwith signs
of right-sided heart failure. The cardiac echo-Doppler ultrasound
method objectiﬁes then PA (80mm Hg of pulmonary arterial sys-
tolic pressure) and note dilatation of the right cavities. The cardiac
MRI does not objectives local recurrence.
Conclusion: PH is dramatic complication of the rupture of the
HC of the right ventricle and aggravates the prognosis of this still
